PortfoliosLab logoPortfoliosLab logo
GRAIL, Inc (GRAL)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US3847471014
IPO Date
Jun 25, 2024

Highlights

Market Cap
$2.10B
Enterprise Value
$1.96B
EPS (TTM)
-$10.95
Total Revenue (TTM)
$147.17M
Gross Profit (TTM)
-$62.57M
EBITDA (TTM)
-$377.82M
Year Range
$20.44 - $118.84
Target Price
$85.40
ROA (TTM)
-13.97%
ROE (TTM)
-15.84%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


GRAIL, Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in GRAIL, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

GRAIL, Inc (GRAL) has returned -39.62% so far this year and 102.35% over the past 12 months.


GRAIL, Inc

1D
10.19%
1M
-2.91%
YTD
-39.62%
6M
-12.60%
1Y
102.35%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 25, 2024, GRAL's average daily return is +0.50%, while the average monthly return is +9.75%. At this rate, your investment would double in approximately 0.6 years.

Historically, 55% of months were positive and 45% were negative. The best month was Sep 2025 with a return of +80.3%, while the worst month was Feb 2026 at -45.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.

On a daily basis, GRAL closed higher 49% of trading days. The best single day was Feb 13, 2025 with a return of +33.9%, while the worst single day was Feb 20, 2026 at -50.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202614.29%-45.58%-2.91%-39.62%
202569.64%27.34%-33.77%35.06%11.35%33.87%-33.47%-4.15%80.33%55.47%20.08%-22.47%379.50%
2024-9.59%0.07%-8.26%-2.48%-1.38%28.96%2.00%5.00%

Benchmark Metrics

GRAIL, Inc has an annualized alpha of 169.15%, beta of 2.28, and R² of 0.13 versus S&P 500 Index. Calculated based on daily prices since June 26, 2024.

  • This stock captured 1322.47% of S&P 500 Index gains and 319.76% of its losses — amplifying both gains and losses, but participating more in upside than downside.
  • R² of 0.13 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
169.15%
Beta
2.28
0.13
Upside Capture
1,322.47%
Downside Capture
319.76%

Return for Risk

Risk / Return Rank

GRAL ranks 72 for risk / return — better than 72% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


GRAL Risk / Return Rank: 7272
Overall Rank
GRAL Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
GRAL Sortino Ratio Rank: 7474
Sortino Ratio Rank
GRAL Omega Ratio Rank: 7575
Omega Ratio Rank
GRAL Calmar Ratio Rank: 6969
Calmar Ratio Rank
GRAL Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for GRAIL, Inc (GRAL) and compare them to a chosen benchmark (S&P 500 Index).


GRALBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.94

0.90

+0.05

Sortino ratio

Return per unit of downside risk

1.80

1.39

+0.42

Omega ratio

Gain probability vs. loss probability

1.26

1.21

+0.05

Calmar ratio

Return relative to maximum drawdown

1.46

1.40

+0.06

Martin ratio

Return relative to average drawdown

3.64

6.61

-2.97

Explore GRAL risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


GRAIL, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the GRAIL, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the GRAIL, Inc was 62.92%, occurring on Feb 23, 2026. The portfolio has not yet recovered.

The current GRAIL, Inc drawdown is 55.47%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-62.92%Jan 23, 202621Feb 23, 2026
-61.12%Feb 18, 202536Apr 8, 2025119Sep 29, 2025155
-36.58%Jul 18, 202455Oct 3, 202443Dec 4, 202498
-27.43%Dec 18, 20242Dec 19, 202421Jan 23, 202523
-23.43%Nov 25, 202524Dec 30, 202515Jan 22, 202639

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of GRAIL, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how GRAIL, Inc is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for GRAL relative to other companies in the Diagnostics & Research industry. Currently, GRAL has a P/S ratio of 13.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for GRAL in comparison with other companies in the Diagnostics & Research industry. Currently, GRAL has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items